查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2105792

全球聚合物基生物材料市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Polymeric Biomaterials Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球聚合物生物材料市場預計將從2025年的26.8億美元成長至2034年的108.9億美元，2026年至2034年的複合年成長率（CAGR）為16.86%。該市場正經歷強勁成長，這主要得益於聚合物生物材料在現代醫療領域（包括整形外科植入、心血管醫療設備、創傷護理產品和組織工程）日益成長的重要性。其優異的生物相容性、柔軟性和耐久性使其適用於各種醫療程序。醫療領域的投資增加、外科手術數量的成長以及對先進醫療設備需求的不斷成長，都推動了市場擴張。持續的研究正在推動具有更優異性能的創新生物材料的開發。

慢性病盛行率上升、人口老化以及對微創醫療手術需求的不斷成長是推動成長要素。醫療機構正在採用先進的聚合物生物材料來改善患者預後並減少術後併發症。製造商正在投資研發生物可吸收聚合物、抗菌材料和客製化生物材料解決方案，以提高安全性和治療效果。再生醫學及其在組織工程領域的應用研究不斷深入，也為產業相關人員創造了巨大的成長機會。

鑑於生物技術和材料科學的快速持續發展，前景極為樂觀。 3D列印、個人化醫療和智慧生物材料的融合預計將在未來幾年為醫療設備的研發帶來重大變革。研發投入的增加、法規核准的加速以及醫療創新的推進，將加速下一代聚合物生物材料的商業化進程。對永續和高性能醫療材料日益成長的需求，將進一步鞏固全球市場的長期發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球聚合物基生物材料市場：依產品類型分類

  • 市場分析、洞察與預測
  • 聚芳醚醚酮（PEEK）
  • 聚乙醇酸（PGA）
  • 聚乳酸（PLA）
  • 聚四氟乙烯（PTFE）和發泡聚四氟乙烯（ePTFE）
  • 聚氨酯
  • 其他產品

第5章 全球聚合物基生物材料市場：依應用分類

  • 市場分析、洞察與預測
  • 神經病學
  • 循環系統
  • 整形外科
  • 眼科
  • 創傷護理
  • 其他用途

第6章 全球聚合物基生物材料市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • BASF SE
    • Bezwada Biomedical LLC
    • Celanese Corporation
    • Corbion NV
    • Covestro AG
    • DSM-Firmenich AG
    • Evonik Industries AG
    • Lubrizol Corporation
    • RTI Surgical（Collagen Solutions）
    • Solvay SA
    • Starch Medical Inc
    • Victrex Manufacturing Limited
    • WL Gore & Associates Inc
簡介目錄
Product Code: VMR112119075

The global polymeric biomaterials market size is expected to reach USD 10.89 Billion in 2034 from USD 2.68 Billion in 2025, growing at a CAGR of 16.86 during 2026-2034.This market is experiencing strong growth as polymeric biomaterials become increasingly important in modern healthcare applications, including orthopedic implants, cardiovascular devices, wound care products, and tissue engineering. Their excellent biocompatibility, flexibility, and durability make them suitable for a wide range of medical procedures. Rising healthcare investments, increasing surgical volumes, and growing demand for advanced medical devices are supporting market expansion. Continuous research is leading to the development of innovative biomaterials with enhanced performance characteristics.

Increasing prevalence of chronic diseases, an aging population, and rising demand for minimally invasive medical procedures are major growth drivers. Healthcare providers are adopting advanced polymeric biomaterials to improve patient outcomes and reduce post-surgical complications. Manufacturers are investing in bioresorbable polymers, antimicrobial materials, and customized biomaterial solutions that enhance safety and treatment effectiveness. Expanding regenerative medicine research and tissue engineering applications are also creating significant opportunities for industry participants.

Future prospects remain highly favorable as biotechnology and material science continue advancing rapidly. The integration of three-dimensional printing, personalized medicine, and smart biomaterials is expected to transform medical device development over the coming years. Growing investments in research, regulatory approvals, and healthcare innovation will accelerate commercialization of next-generation polymeric biomaterials. Increasing demand for sustainable and high-performance medical materials will further strengthen long-term global market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

  • Polyaryletheretherketone (PEEK)
  • Polyglycolic Acid (PGA)
  • Polylactic Acid (PLA)
  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Polyurethanes
  • Other Products

By Application

  • Neurology
  • Cardiology
  • Orthopedics
  • Ophthalmology
  • Wound Care
  • Other Applications

COMPANIES PROFILED

  • BASF SE, Bezwada Biomedical LLC, Celanese Corporation, Corbion NV, Covestro AG, DSM-Firmenich AG, Evonik Industries AG, Lubrizol Corporation, RTI Surgical (Collagen Solutions), Solvay SA, Starch Medical Inc., Victrex Manufacturing Limited, W. L. Gore & Associates Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL POLYMERIC BIOMATERIALS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Polyaryletheretherketone (PEEK) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Polyglycolic Acid (PGA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Polylactic Acid (PLA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Polyurethanes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POLYMERIC BIOMATERIALS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Wound Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POLYMERIC BIOMATERIALS MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product Type
    • 6.2.2 By Application
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product Type
    • 6.3.2 By Application
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product Type
    • 6.4.2 By Application
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product Type
    • 6.5.2 By Application
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product Type
    • 6.6.2 By Application
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL POLYMERIC BIOMATERIALS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 BASF SE
    • 8.2.2 Bezwada Biomedical LLC
    • 8.2.3 Celanese Corporation
    • 8.2.4 Corbion NV
    • 8.2.5 Covestro AG
    • 8.2.6 DSM-Firmenich AG
    • 8.2.7 Evonik Industries AG
    • 8.2.8 Lubrizol Corporation
    • 8.2.9 RTI Surgical (Collagen Solutions)
    • 8.2.10 Solvay SA
    • 8.2.11 Starch Medical Inc
    • 8.2.12 Victrex Manufacturing Limited
    • 8.2.13 W. L. Gore & Associates Inc